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INTRODUCTION
Gradual tissue expansion is a natural physiological phenomenon that occurs during growth, pregnancy, or morbid obesity; however, it is also an established therapeutic method for treating tissue defects. Tissue expansion is applied therapeutically with specific devices, including an internal tissue expander or an internal/external distraction osteogenesis system. Distraction osteogenesis can elongate limbs, 1,2 the cranial bone, or the maxillofacial bone 3 without bone grafting; an internal tissue expander is widely used in tissue reconstruction to expand healthy skin or soft tissue adjacent to defects imparted by trauma or surgery, like those due to mastectomy. [4] [5] [6] Thus, gradual tissue expansion has been widely used as a reliable way to regenerate tissue, and it is considered a viable alternative to transplantation. Tissue expansion procedures can expand the target tissue to over twice the volume of the original tissue. The expansion capacity is based on the potential of target tissues that can expand and regenerate, like the skin, bone, or soft tissues. The regenerating potential has been attributed to the number (density) and potential of resident stem/progenitor cells specific to each tissue; thus, irradiated tissue has a limited potential for expansion.
expansion effects could be reversed, but significant expansion effects may be achieved when the distractive force was continuously applied for a sufficient period of time. 7, 8 An external force is transduced into cells and subcellular structures through various mechanical disturbances, including shear, stretch, tension, distraction, and compression. These mechanical disturbances are converted into biological signals by a series of mechanotransduction pathways. 10 There are many different cellular responses to mechanical forces, and many different second messengers that mediate these responses, including integrins or cadherins. 10 It has been shown that applied mechanical forces can affect tissue growth, cellular function, and even survival. [11] [12] [13] [14] [15] [16] Moreover, physical interactions with the extracellular matrix can significantly influence stem cell behavior. 17 Studies on gradual tissue expansion are scarce, and, to our knowledge, no experimental research has been reported for soft tissue expansion in response to an external force.
Therefore, in this study, we created an original animal model to examine cellular events during gradual tissue expansion with external tissue suspension. In any organ, tissueresident or circulation-derived stem/progenitor cells are involved in a variety of tissue growth, repair, regeneration, and remodeling processes. We hypothesized that tissueresident stem/progenitor cells would play an important role in the expansion process.
We sought to evaluate the therapeutic potential of external tissue suspension for soft tissue enlargement. In a preliminary study, we found that soft tissue, particularly adipose tissue, was expanded after 4-weeks of external suspension, but the expansion was not sustained over a long time. Therefore, we performed an additional experiment to evaluate the effect of administering controlled release basic fibroblast growth factor This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
(bFGF) on the expanded tissue in an effort to prevent reversal and preserve tissue enlargement. Adipose tissue is known to contain multipotent mesenchymal cells, 18, 19 also referred to as adipose-derived stem, stromal, or progenitor cells (ASC). 20, 21 Compared to bone marrow stem cells, adipose tissue mesenchymal stem cells are easier to isolate, require less invasive procedures, and provide higher cell yields. Thus, ASCs hold promise for therapeutic use in tissue engineering and regenerative medicine. 20 In this study, we also analyzed in detail the involvement of ASCs in the tissue expansion/remodeling process.
MATERIALS AND METHODS

Mouse models for external tissue suspension
Eight-week-old Balb/c nude mice were anesthetized with intraperitoneal pentobarbital (50 mg/kg weight), and the back skin (30 mm diameter) was placed under continuous suspension, as follows. A suspension device, originally prepared for this purpose (Hiroki Corp., Kanagawa, Japan), was placed on a designated site in the back (Fig. 1A) .
The device comprised a small round plate (8 mm diameter) with a durable thread attached, that was placed on the skin. A round, adhesive, 30 mm-diameter film was placed over the plate, and the thread was pulled through a hole in the middle of the film. The film adhered to the plate and the back skin; thus, a pull on the string lifted both the plate and the surrounding skin. A plastic cap was then placed over the skin, film, and plate, and the thread was pulled through a hole and attached at the top of the plastic cap ( Supplementary Fig.1 ). Sufficient force was applied to cause suspension of the patch of skin in contact with the adhesive film. The applied suspension force was measured with a tension gage (ST02, Sanko Seikohjo Co. Ltd., Tokyo, Japan) and was 1.64±0.26 N (mean±SEM) immediately after device application. The adhesive film was exchanged every 5 days. The suspended skin and underlying soft tissue was harvested at days 0, 3, 7, 14, or 28 (n= 6 in each group). For the 42-day animals (n=12), one of two types of gelatin microspheres (see below) were injected into the subcutaneous tissue at the suspension site on day 28; then the suspension device was not applied between days 28 and day 42. The harvested tissue samples were weighed and subjected to the assays described below.
bFGF-incorporated gelatin microspheres
Gelatin microspheres that contained bFGF or vehicle alone were prepared with a modification of a previously described method. 22 In brief, 2 mg of gelatin microspheres were mixed with 20 µl phosphate buffered saline (PBS), with or without bFGF (0.1 µg). To the resulting 20 µl hydrogel, we added 80 µl PBS, to obtain a 100 µl hydrogel mixture, containing bFGF or vehicle alone. On day 28, the suspension device was removed, and the 100µl hydrogel was carefully injected into the back skin under anesthesia (n=6 in each group, with or without 0.1 µg bFGF).
To confirm the location of injected gelatin microspheres, we prepared frozen sections of skin samples. Next, the supernatant was diluted 10× with an enzyme-extracting reagent, the mixture was dispensed into the wells of a 96-well plate, two volumes of a substrate reagent was added, and the optical absorption was measured at 340 nm for 10 minutes. GPDH activity was calculated based on the following formula: GPDH (U/ml) =∆OD×0.482×5
(∆OD is the change in optical density per minute).
Whole mount staining of living subcutaneous adipose tissue
Visualization of living skin and subcutaneous tissue was performed with the procedure described by Nishimura et al. 23 Briefly, harvested skin samples were cut into 3 mm pieces within 2 hours after sacrifice, and the samples were incubated with the following 
Histological detection of apoptosis
To detect apoptosis in subcutaneous adipose tissue, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) was performed with an In-Situ Cell Death Detection Kit (Roche Diagnostics, Mannheim, Germany). The protocol was provided by the manufacture.
RESULTS
Macroscopic and weight changes of suspended tissue samples
After 28 days of continuous tissue suspension, the back skin appeared thickened and wrinkled, with a thick subcutaneous layer that appeared reddish, probably due to an increase in vasculature, while the skin was flat with a thin, pale-colored subcutaneous fatty layer at baseline (Fig. 1B) . The weight of the suspended tissue increased with time and reached maximum enlargement on day 28. However, the weight was substantially lower on day 42, 14 days after removing the suspension device (Fig. 1C ).
On day 28, the suspension device was removed, and gelatin microspheres containing bFGF or vehicle were injected into the expanded subcutaneous tissue. The presence of microspheres in the subcutaneous adipose tissue was confirmed by visualization with a fluorescence microscope (Supplemental online Fig. 2A ). On day 42, the weights of harvested skin samples that were treated with bFGF microspheres were significantly higher (0.600 ± 0.045 g, n=5) than the control skin weights (0.371 ± 0.016 g, n=6) ( Fig.   1C ).
Histological and adipose volume (GPDH activity) changes in suspended tissues
Hematoxylin and eosin stained sections of tissues harvested during continuous suspension through day 28 showed a thickening of subcutaneous adipose tissue and muscle layers; in particular, an enlargement of the adipose tissue was noted ( Fig. 2A ).
On days 3 and 7, small-sized adipocytes appeared throughout the subcutaneous adipose GPDH activity is known to increase when preadipocytes differentiate into adipocytes.
We found that GPDH activity was elevated in the tissue samples from day 3 to day 28, but then declined on day 42 (Fig. 2B ). The decline in GPDH on day 42 was partly prevented by administration of bFGF microspheres (0.101 ± 0.016 U/g, n=3) compared to controls (0.080 ± 0.008 U/g, n=3), but the difference was not statistically significant.
These results suggested that the volume of subcutaneous adipose tissue increased under continuous external suspension and reversed after releasing the suspension. Moreover, the treatment with bFGF contributed to preservation of the enlarged adipose tissue.
Cellular events evaluated by whole mount staining
Triple-fluorescence staining allowed three-dimensional analysis. Whole mount specimens were immediately stained without any fixing or sectioning procedures; thus, the obtained images reflected the original tissue structures, including adipocytes and capillaries. The reversible enlargement of subcutaneous adipose tissues by external tissue suspension was assessed by the whole mount histology ( well-organized network. On days 7, 14, and 28, capillaries appeared elongated, distended in the direction of the external suspension. In the group treated with bFGF microspheres, the enlarged fat tissue volume was retained compared to the control group, and the increased density of vascular structures was also relatively preserved (Fig. 3B ).
Increased number of small adipocytes under suspension
Small adipocytes, suggesting ongoing adipogenesis, were counted in microsections stained for perilipin (Fig. 4A) . Under external suspension, the number of small adipocytes increased and peaked on day7; thereafter, it declined to the baseline level on day28, and treatment with bFGF-incorporated microspheres did not influence the number (Fig. 4B ).
Increased number of capillaries in subcutaneous adipose tissue
Lectin-positive capillaries increased in number under tissue suspension and peaked on day 7 (Fig. 5A) . On day 42, the number of capillaries in subcutaneous adipose tissue treated with bFGF (38 ± 13) was significantly higher than that of controls (15 ± 3) (Fig.   5B ). These results suggested that angiogenesis was associated with adipogenesis under external tissue suspension.
Proliferating cells in subcutaneous adipose tissue under suspension
Histological analysis of day 14 samples showed that most Ki67+ proliferating cells were CD34+ and lectin−, which suggested that they were ASCs (Figs. 6A, 6B ). CD34+
ASCs increased in number and were most frequently observed in the superficial adipose layer immediately under the dermis. Lectin+/CD34+ cells were also This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
occasionally observed, perhaps due to the transdifferentiation of cells from ASCs to vascular endothelial cells (Fig. 6C) . The Lectin+/CD34+ cells were most frequently observed on day 14 ( Supplementary Fig. 3 ).
Sequential changes in the frequency of CD34+/Ki67+ cells (proliferating ASCs) was measured during external suspension (Fig. 7A) . The frequency started to increase on day 7; this suggested a regenerating process like adipogenesis and/or angiogenesis due to external suspension (Fig. 7B) . On day 42, the percentage of CD34+/Ki67+ cells was higher in the adipose tissue treated with bFGF (11.2 ± 3.3 %) microspheres than in the controls (8.6 ± 1.5 %) (p=0.06; n=3).
Apoptosis in subcutaneous adipose tissue after releasing suspension
To examine acute changes after removing the suspension device, some samples were 
DISCUSSION
Our results showed that application of continuous external suspension induced soft tissue enlargement, particularly in the subcutaneous adipose layer. However, the enlargement was reversible as far as external suspension was applied for up to 4 weeks. and the extent of angiogenesis may determine the partial pressure of tissue oxygen and affect metabolic functions of the generated adipocytes. Capillaries increased in density during the angiogenesis process, and also after treatment of bFGF along with discontinuation of external suspension.
During the 4-week expansion period, several dynamic cellular events were observed that were associated with tissue remodeling, including: the proliferation and differentiation of cells, like ASCs; angiogenetic changes, including increased capillary density and elongation of vessels along the direction of tissue suspension; and 17 There are a variety of mechanotransduction molecules that regulate stem cell differentiation, including the actin cytoskeleton, mechano-and osmotically sensitive ion channels, and chromatin remodeling enzymes. 17 This study provides in vivo evidence that mechanical force was able to activate resident stem cells and induce dynamic tissue remodeling, accompanied by adipogenesis and angiogenesis, although the detailed mechanical transduction pathways remain to be definitively determined.
Several phenomena observed in this study reflected influences of mechanical forces, This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
such as a higher density of proliferating cells in superficial layers and elongated vessels arranged parallel to the direction of the external force.
In conclusion, continuous external suspension for 4 weeks induced reversible tissue enlargement, particularly in adipose tissue. Adipose-resident progenitor cells (ASCs)
were highly involved in the dynamic expansion/remodeling process; ASCs actively proliferated, differentiated, and contributed to adipogenesis and angiogenesis. Although discontinuation of the external force resulted in a reduction in the enlarged tissue volume, the enlarged tissue could be preserved and capillary density was increased by treatment of controlled release bFGF. These results suggested that an external force can induce soft tissue engineering with a clinically useful significance and the combination of tissue suspension with an external device and controlled release of bFGF has potential as a therapy for soft tissue expansion that does not require cell transplantation.
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